Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarworth Gp Regulatory News (HWG)

Share Price Information for Harworth Gp (HWG)

Share Price is delayed by 15 minutes
Get Live Data
125.60    1.00 (0.80%)
Bid:
125.40
Ask:
129.80
Spread: 4.40 (3.509%)
Market Cap: £408.45m
HWG Live PriceLast checked at - London Stock Exchange

Intraday Harworth Gp Share Chart

Rule 8.3 - UK COAL PLC

22 Mar 2010 14:50

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1) INVESCO LIMITED
Company dealt in UK COAL PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) ORDINARY 1p SHARES
Date of dealing 19 MARCH 2010

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short

Number (%) Number (%)
(1) Relevant securities 26,349,537 8.80%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total 26,349,537 8.80%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short

Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

(c) Rights to subscribe (Note 3)

Class of relevant security: Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of securities Price per unit (Note 5)
Sale 15,434 0.77 USD

(b) Derivatives transactions (other than options)

Product name,

e.g. CFD

Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise

price

Type, e.g. American, European etc. Expiry

date

Option money

paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) YES/NO

Date of disclosure 22 MARCH 2010
Contact name ON BEHALF OF INVESCO LIMITED
Telephone number 01491 416381
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Copyright Business Wire 2010

Date   Source Headline
28th May 202612:57 pmRNSIssue of Shares and Total Voting Rights
28th May 202611:17 amRNSDirector/PDMR Shareholding
26th May 20269:01 amRNSHarworth expands £275m RCF syndicate
19th May 20269:35 amRNSDirector/PDMR Shareholding
19th May 20269:30 amRNSIssue of Shares and Total Voting Rights
18th May 202611:42 amRNSResults of Annual General Meeting
18th May 20267:01 amRNSTony Quinlan joins Harworth Board
18th May 20267:00 amRNSAGM Statement
14th May 20269:34 amRNSDirector/PDMR Shareholding
14th May 20269:33 amRNSIssue of Shares and Total Voting Rights
27th Apr 20267:00 amRNSHarworth and Microsoft receive resolution to grant
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
16th Apr 20263:27 pmRNSDirector/PDMR Shareholding
16th Apr 20263:19 pmRNSIssue of Shares and Total Voting Rights
14th Apr 20267:00 amRNSPublication of ARA, Notice of AGM and NZC Report
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:00 amRNSDirector/PDMR Shareholding
24th Mar 20269:26 amRNSDirector/PDMR Shareholding
23rd Mar 20269:00 amRNSDirector/PDMR Shareholding
20th Mar 20269:00 amRNSDirector/PDMR Shareholding
18th Mar 20263:26 pmRNSIssue of Shares and Total Voting Rights
17th Mar 20267:00 amRNSFull Year Results for year ended 31 Dec 2025
17th Mar 20267:00 amRNSFull Year Results for year ended 31 Dec 2025
11th Mar 20264:07 pmRNSDirector/PDMR Shareholding
11th Mar 20264:07 pmRNSDirector/PDMR Shareholding
11th Mar 20264:05 pmRNSIssue of Shares and Total Voting Rights
11th Mar 20264:05 pmRNSIssue of Shares and Total Voting Rights
2nd Mar 202611:29 amRNSBlock admission - application to LSE
25th Feb 20268:00 amRNSAppointment of joint corporate broker
17th Feb 20262:12 pmRNSDirector/PDMR Shareholding
17th Feb 20262:08 pmRNSIssue of Shares and Total Voting Rights
12th Feb 20267:53 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSTrading Update FY-2025
19th Jan 202610:07 amRNSDirector/PDMR Shareholding
19th Jan 20269:55 amRNSIssue of Shares and Total Voting Rights
19th Jan 20267:00 amRNSHarworth delivers FY2025 headline sales of £110.2m
24th Dec 20257:30 amRNSHolding(s) in Company
24th Dec 20257:30 amRNSHolding(s) in Company
18th Dec 20257:00 amRNSHarworth secures 267,000 sq ft of I&L lettings
16th Dec 20253:28 pmRNSDirector/PDMR Shareholding
16th Dec 20253:23 pmRNSIssue of Shares and Total Voting Rights
2nd Dec 20255:06 pmRNSHolding(s) in Company
26th Nov 202511:00 amRNSDirector Declaration
26th Nov 20257:00 amRNSNew £275 million Revolving Credit Facility
25th Nov 20254:47 pmRNSDirector/PDMR Shareholding
18th Nov 20253:33 pmRNSDirector/PDMR Shareholding
18th Nov 20253:25 pmRNSIssue of Shares and Total Voting Rights
17th Nov 20259:15 amRNSBlock listing Interim Review
12th Nov 20252:39 pmRNSIssue of Shares and Total Voting Rights
5th Nov 20259:00 amRNSStatement re further consultation on the DRR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.